You are here

  • Home
  • Archive
  • Volume 9, Issue 9
  • Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study

 

Online download statistics by month:

Online download statistics by month: September 2021 to August 2024

AbstractFullPdf
Sep 2021447448148
Oct 202122322373
Nov 202115615656
Dec 2021959529
Jan 2022555718
Feb 2022869735
Mar 2022818940
Apr 202210010136
May 202211713048
Jun 202211712028
Jul 202212012427
Aug 202215215329
Sep 202213213627
Oct 202213213318
Nov 202211711721
Dec 2022979722
Jan 20238613129
Feb 202315015028
Mar 202314014132
Apr 2023939420
May 202311011017
Jun 202312812830
Jul 202311811830
Aug 202315115127
Sep 202314014014
Oct 202315816147
Nov 202318318432
Dec 202320120124
Jan 202421228
Feb 202412912920
Mar 202423023241
Apr 202420720734
May 202419519623
Jun 202422322426
Jul 202432933133
Aug 202418218927
Total540155151197